Neuroimaging in amyotrophic lateral sclerosis

Martin R. Turner, Federica Agosta, Peter Bede, Varan Govind, Dorothée Lulé, Esther Verstraete

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The catastrophic system failure in amyotrophic lateral sclerosis is characterized by progressive neurodegeneration within the corticospinal tracts, brainstem nuclei and spinal cord anterior horns, with an extra-motor pathology that has overlap with frontotemporal dementia. The development of computed tomography and, even more so, MRI has brought insights into neurological disease, previously only available through post-mortem study. Although largely research-based, radionuclide imaging has continued to provide mechanistic insights into neurodegenerative disorders. The evolution of MRI to use advanced sequences highly sensitive to cortical and white matter structure, parenchymal metabolites and blood flow, many of which are now applicable to the spinal cord as well as the brain, make it a uniquely valuable tool for the study of a multisystem disorder such as amyotrophic lateral sclerosis. This comprehensive review considers the full range of neuroimaging techniques applied to amyotrophic lateral sclerosis over the last 25 years, the biomarkers they have revealed and future developments.

Original languageEnglish
Pages (from-to)319-337
Number of pages19
JournalBiomarkers in Medicine
Volume6
Issue number3
DOIs
StatePublished - Jun 1 2012

Fingerprint

Neuroimaging
Amyotrophic Lateral Sclerosis
Magnetic resonance imaging
Biomarkers
Pathology
Metabolites
Radioisotopes
Tomography
Frontotemporal Dementia
Brain
Pyramidal Tracts
Blood
Imaging techniques
Radionuclide Imaging
Neurodegenerative Diseases
Brain Stem
Spinal Cord
Research

Keywords

  • diffusion tensor imaging
  • functional imaging
  • magnetic resonance spectroscopy
  • morphometry
  • motor neuron disease
  • MRI
  • PET
  • resting state

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Turner, M. R., Agosta, F., Bede, P., Govind, V., Lulé, D., & Verstraete, E. (2012). Neuroimaging in amyotrophic lateral sclerosis. Biomarkers in Medicine, 6(3), 319-337. https://doi.org/10.2217/bmm.12.26

Neuroimaging in amyotrophic lateral sclerosis. / Turner, Martin R.; Agosta, Federica; Bede, Peter; Govind, Varan; Lulé, Dorothée; Verstraete, Esther.

In: Biomarkers in Medicine, Vol. 6, No. 3, 01.06.2012, p. 319-337.

Research output: Contribution to journalArticle

Turner, MR, Agosta, F, Bede, P, Govind, V, Lulé, D & Verstraete, E 2012, 'Neuroimaging in amyotrophic lateral sclerosis', Biomarkers in Medicine, vol. 6, no. 3, pp. 319-337. https://doi.org/10.2217/bmm.12.26
Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomarkers in Medicine. 2012 Jun 1;6(3):319-337. https://doi.org/10.2217/bmm.12.26
Turner, Martin R. ; Agosta, Federica ; Bede, Peter ; Govind, Varan ; Lulé, Dorothée ; Verstraete, Esther. / Neuroimaging in amyotrophic lateral sclerosis. In: Biomarkers in Medicine. 2012 ; Vol. 6, No. 3. pp. 319-337.
@article{879fa903417841c4b9dee1d00f042499,
title = "Neuroimaging in amyotrophic lateral sclerosis",
abstract = "The catastrophic system failure in amyotrophic lateral sclerosis is characterized by progressive neurodegeneration within the corticospinal tracts, brainstem nuclei and spinal cord anterior horns, with an extra-motor pathology that has overlap with frontotemporal dementia. The development of computed tomography and, even more so, MRI has brought insights into neurological disease, previously only available through post-mortem study. Although largely research-based, radionuclide imaging has continued to provide mechanistic insights into neurodegenerative disorders. The evolution of MRI to use advanced sequences highly sensitive to cortical and white matter structure, parenchymal metabolites and blood flow, many of which are now applicable to the spinal cord as well as the brain, make it a uniquely valuable tool for the study of a multisystem disorder such as amyotrophic lateral sclerosis. This comprehensive review considers the full range of neuroimaging techniques applied to amyotrophic lateral sclerosis over the last 25 years, the biomarkers they have revealed and future developments.",
keywords = "diffusion tensor imaging, functional imaging, magnetic resonance spectroscopy, morphometry, motor neuron disease, MRI, PET, resting state",
author = "Turner, {Martin R.} and Federica Agosta and Peter Bede and Varan Govind and Doroth{\'e}e Lul{\'e} and Esther Verstraete",
year = "2012",
month = "6",
day = "1",
doi = "10.2217/bmm.12.26",
language = "English",
volume = "6",
pages = "319--337",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Neuroimaging in amyotrophic lateral sclerosis

AU - Turner, Martin R.

AU - Agosta, Federica

AU - Bede, Peter

AU - Govind, Varan

AU - Lulé, Dorothée

AU - Verstraete, Esther

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The catastrophic system failure in amyotrophic lateral sclerosis is characterized by progressive neurodegeneration within the corticospinal tracts, brainstem nuclei and spinal cord anterior horns, with an extra-motor pathology that has overlap with frontotemporal dementia. The development of computed tomography and, even more so, MRI has brought insights into neurological disease, previously only available through post-mortem study. Although largely research-based, radionuclide imaging has continued to provide mechanistic insights into neurodegenerative disorders. The evolution of MRI to use advanced sequences highly sensitive to cortical and white matter structure, parenchymal metabolites and blood flow, many of which are now applicable to the spinal cord as well as the brain, make it a uniquely valuable tool for the study of a multisystem disorder such as amyotrophic lateral sclerosis. This comprehensive review considers the full range of neuroimaging techniques applied to amyotrophic lateral sclerosis over the last 25 years, the biomarkers they have revealed and future developments.

AB - The catastrophic system failure in amyotrophic lateral sclerosis is characterized by progressive neurodegeneration within the corticospinal tracts, brainstem nuclei and spinal cord anterior horns, with an extra-motor pathology that has overlap with frontotemporal dementia. The development of computed tomography and, even more so, MRI has brought insights into neurological disease, previously only available through post-mortem study. Although largely research-based, radionuclide imaging has continued to provide mechanistic insights into neurodegenerative disorders. The evolution of MRI to use advanced sequences highly sensitive to cortical and white matter structure, parenchymal metabolites and blood flow, many of which are now applicable to the spinal cord as well as the brain, make it a uniquely valuable tool for the study of a multisystem disorder such as amyotrophic lateral sclerosis. This comprehensive review considers the full range of neuroimaging techniques applied to amyotrophic lateral sclerosis over the last 25 years, the biomarkers they have revealed and future developments.

KW - diffusion tensor imaging

KW - functional imaging

KW - magnetic resonance spectroscopy

KW - morphometry

KW - motor neuron disease

KW - MRI

KW - PET

KW - resting state

UR - http://www.scopus.com/inward/record.url?scp=84862889813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862889813&partnerID=8YFLogxK

U2 - 10.2217/bmm.12.26

DO - 10.2217/bmm.12.26

M3 - Article

C2 - 22731907

AN - SCOPUS:84862889813

VL - 6

SP - 319

EP - 337

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 3

ER -